199 related articles for article (PubMed ID: 38676792)
1. Patient-Derived Xenograft Models in Cancer Research: Methodology, Applications, and Future Prospects.
Aslani S; Saad MI
Methods Mol Biol; 2024; 2806():9-18. PubMed ID: 38676792
[TBL] [Abstract][Full Text] [Related]
2. Patient-Derived Xenografts: Historical Evolution, Immunocompromised Host Models, and Translational Significance.
Thompson J; Saad MI
Methods Mol Biol; 2024; 2806():1-8. PubMed ID: 38676791
[TBL] [Abstract][Full Text] [Related]
3. Patient-Derived Xenograft Models for Translational Prostate Cancer Research and Drug Development.
Philp LK
Methods Mol Biol; 2024; 2806():153-185. PubMed ID: 38676802
[TBL] [Abstract][Full Text] [Related]
4. Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M; Amant F; Biankin AV; Budinská E; Byrne AT; Caldas C; Clarke RB; de Jong S; Jonkers J; Mælandsmo GM; Roman-Roman S; Seoane J; Trusolino L; Villanueva A
Cancer Discov; 2014 Sep; 4(9):998-1013. PubMed ID: 25185190
[TBL] [Abstract][Full Text] [Related]
5. Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
Chen Y; Zhang R; Wang L; Correa AM; Pataer A; Xu Y; Zhang X; Ren C; Wu S; Meng QH; Fujimoto J; Jensen VB; Antonoff MB; Hofstetter WL; Mehran RJ; Pisimisis G; Rice DC; Sepesi B; Vaporciyan AA; Walsh GL; Swisher SG; Roth JA; Heymach JV; Fang B
Cancer; 2019 Nov; 125(21):3738-3748. PubMed ID: 31287557
[TBL] [Abstract][Full Text] [Related]
6. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenograft models for the study of benign human neoplasms.
de Souza JC; Miguita L; Gomez RS; Gomes CC
Exp Mol Pathol; 2021 Jun; 120():104630. PubMed ID: 33744281
[TBL] [Abstract][Full Text] [Related]
8. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
[TBL] [Abstract][Full Text] [Related]
9. Patient-Derived Xenograft Models of Epithelial Ovarian Cancer for Preclinical Studies.
Heo EJ; Cho YJ; Cho WC; Hong JE; Jeon HK; Oh DY; Choi YL; Song SY; Choi JJ; Bae DS; Lee YY; Choi CH; Kim TJ; Park WY; Kim BG; Lee JW
Cancer Res Treat; 2017 Oct; 49(4):915-926. PubMed ID: 28052650
[TBL] [Abstract][Full Text] [Related]
10. Development and Expansion of Patient-Derived Xenografts for Endometrial Cancer.
Sengal AT; Pollock PM
Methods Mol Biol; 2024; 2806():101-115. PubMed ID: 38676799
[TBL] [Abstract][Full Text] [Related]
11. Fidelity of a PDX-CR model for bladder cancer.
Mondal AM; Ma AH; Li G; Krawczyk E; Yuan R; Lu J; Schlegel R; Stamatakis L; Kowalczyk KJ; Philips GK; Pan CX; Liu X
Biochem Biophys Res Commun; 2019 Sep; 517(1):49-56. PubMed ID: 31303270
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
Rosato RR; Dávila-González D; Choi DS; Qian W; Chen W; Kozielski AJ; Wong H; Dave B; Chang JC
Breast Cancer Res; 2018 Sep; 20(1):108. PubMed ID: 30185216
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived xenograft models for personalized medicine in colorectal cancer.
Xie J; Lin Y
Clin Exp Med; 2020 May; 20(2):167-172. PubMed ID: 32100151
[TBL] [Abstract][Full Text] [Related]
14. Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
Karalis JD; Yoon LY; Hammer STG; Hong C; Zhu M; Nassour I; Ju MR; Xiao S; Castro-Dubon EC; Agrawal D; Suarez J; Reznik SI; Mansour JC; Polanco PM; Yopp AC; Zeh HJ; Hwang TH; Zhu H; Porembka MR; Wang SC
J Transl Med; 2022 Mar; 20(1):116. PubMed ID: 35255940
[TBL] [Abstract][Full Text] [Related]
15. [Knowledge and practice of patient-derived xenograft models in leukemia].
Kato I
Rinsho Ketsueki; 2022; 63(9):1335-1343. PubMed ID: 36198560
[TBL] [Abstract][Full Text] [Related]
16. Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice.
Choi Y; Lee S; Kim K; Kim SH; Chung YJ; Lee C
Exp Mol Med; 2018 Aug; 50(8):1-9. PubMed ID: 30089794
[TBL] [Abstract][Full Text] [Related]
17. Patient-derived xenograft model in colorectal cancer basic and translational research.
Liu X; Xin Z; Wang K
Animal Model Exp Med; 2023 Feb; 6(1):26-40. PubMed ID: 36543756
[TBL] [Abstract][Full Text] [Related]
18. Maintaining Tumor Heterogeneity in Patient-Derived Tumor Xenografts.
Cassidy JW; Caldas C; Bruna A
Cancer Res; 2015 Aug; 75(15):2963-8. PubMed ID: 26180079
[TBL] [Abstract][Full Text] [Related]
19. Patient-derived xenograft (PDX) models in basic and translational breast cancer research.
Dobrolecki LE; Airhart SD; Alferez DG; Aparicio S; Behbod F; Bentires-Alj M; Brisken C; Bult CJ; Cai S; Clarke RB; Dowst H; Ellis MJ; Gonzalez-Suarez E; Iggo RD; Kabos P; Li S; Lindeman GJ; Marangoni E; McCoy A; Meric-Bernstam F; Piwnica-Worms H; Poupon MF; Reis-Filho J; Sartorius CA; Scabia V; Sflomos G; Tu Y; Vaillant F; Visvader JE; Welm A; Wicha MS; Lewis MT
Cancer Metastasis Rev; 2016 Dec; 35(4):547-573. PubMed ID: 28025748
[TBL] [Abstract][Full Text] [Related]
20. Applications of patient-derived tumor xenograft models and tumor organoids.
Yoshida GJ
J Hematol Oncol; 2020 Jan; 13(1):4. PubMed ID: 31910904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
